Development and perspectives of the purinoceptor concept

Journal of Autonomic Pharmacology

Volumn 16, Issue 6, 1996, Pages 295-302

  Burnstock, G ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

2 METHYLTHIOADENOSINE TRIPHOSPHATE; ADENOSINE TRIPHOSPHATE; ALPHA,BETA METHYLENEADENOSINE TRIPHOSPHATE; CIBACRON BLUE F3GA; DIADENOSINE POLYPHOSPHATE; GUANINE NUCLEOTIDE BINDING PROTEIN; PURINE; PURINE P2 RECEPTOR; PURINE P2X RECEPTOR; PURINE P2Y RECEPTOR; PURINE RECEPTOR; PURINERGIC RECEPTOR AFFECTING AGENT; PYRIMIDINE; RECEPTOR SUBTYPE; SURAMIN; UNCLASSIFIED DRUG;

CARDIOVASCULAR SYSTEM; CLASSIFICATION; CONFERENCE PAPER; ENDOTHELIUM CELL; GENE EXPRESSION; HUMAN; HYPERTENSION; NEUROTRANSMISSION; NONADRENERGIC NONCHOLINERGIC NERVE; NONHUMAN; SENSORY NERVE; SIGNAL TRANSDUCTION; SMOOTH MUSCLE; SYMPATHETIC NERVE; TISSUE DISTRIBUTION;

EID: 0030427128     PISSN: 01441795     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1474-8673.1996.tb00039.x     Document Type: Conference Paper

References (90)

1. ABBRACCHIO, M. & BURNSTOCK, G. (1994). Purinoceptors: are there families of P2X and P2Y purinoceptors? Pharmacol. Ther., 64, 445-475.
2. ABEBE, W., MAKUJINA, S.H. & MUSTAFA, S.J. (1994). Adenosine receptor-mediated relaxation of porcine coronary artery in presence and absence of endothelium. Am. J. Physiol., 266, H2018-H2025.
3. BARNARD, E.A., BURNSTOCK, G. & WEBB, T.E. (1994). G protein-coupled receptors for ATP and other nucleotides: a new receptor family. TIPS, 15, 67-70.
4. BARNARD, E.A., SIMON, J. & KUNAPULI, S.P. (1996). The diverse series of recombinant P2Y-purinoceptors. Ciba Foundation Symposium, 198. In: P2 Purinoceptors: Localization, Function and Transduction Mechanisms. John Wiley and Sons, Chichester. pp. 166-188.
5. 2+-permeable channel activated by ATP in smooth muscle. Nature, 328, 275-278.
6. BERNE, R.M. (1963). Cardiac nucleotides in hypoxia: possible role in regulation of coronary blood flow. Am. J. Physiol., 204, 317-322.
7. 3H]α,β-methylene ATP binding sites in rat brain and spinal cord. Neuroreport, 5, 1601-1604.
8. 2-purinoceptors: from molecular biology to functional responses. TIPS, 16, 133-139.
9. BODIN, P. & BURNSTOCK, G. (1995). Synergistic effect of acute hypoxia on flow-induced release of ATP from cultured endothelial cells. Experientia, 51, 256-259.
10. BODIN, P., MILNER, P., WINTER, R. & BURNSTOCK, G. (1992). Chronic hypoxia changes the ratio of endothelin to ATP release from rat aortic endothelial cells exposed to high flow. Proc. Roy. Soc. Lond., Ser. B, 247, 131-135.
11. BRAKE, A.J., WAGENBACH, M.J. & JULIUS, D. (1994). New structural motif for ligand-gated ion channels defined by an ionotropic ATP receptor. Nature, 371, 519-523.
12. BROCK, J.A. & VAN HELDEN, D.E. (1995). Enhanced excitatory junction potentials in mesenteric arteries from spontaneously hypertensive rats. Pflügers Arch. Eur. J. Physiol., 430, 901-908.
13. BURNSTOCK, G. (1972). Purinergic nerves. Pharmacol. Rev., 24, 509-581.
14. BURNSTOCK, G. (1976). Purinergic receptors. J. Theor. Biol., 62, 491-503.
15. BURNSTOCK, G. (1978). A basis for distinguishing two types of purinergic receptor. In: Cell Membrane Receptors for Drugs and Hormones: A Multidisciplinary Approach. pp. 107-118. Eds. R.W. Straub & L. Bolis, Raven Press, New York.
16. BURNSTOCK, G. (1981). Nervous control of cerebral blood vessels: a new hypothesis for the mechanisms underlying migraine. In: Progress in Migraine Research 1. pp. 17-32. Eds. F. Clifford-Rose & K.J. Zilkha, Pitman Medical, London.
17. BURNSTOCK, G. (1988). Sympathetic purinergic transmission in small blood vessels. TIPS, 9, 116-117.
18. BURNSTOCK, G. (1990). Dual control of local blood flow by purines. In: Biological Actions of Extracellular ATP. N.Y. Acad. Sci. vol. 603, pp. 31-45. Eds. G.R. Dubyak & J.A. Fedan, New York Academy of Sciences, New York.
19. BURNSTOCK, G. (1993a). Hypoxia, endothelium and purines. Drug Development Research, 28, 301-305.
20. BURNSTOCK, G. (1993b). Introduction: Changing face of autonomic and sensory nerves in the circulation. In: Vascular Innervation and Receptor Mechanisms: New Perspectives, pp. 1-22. Eds. L. Edvinsson and R. Uddman, Anonymous Academic Press Inc, USA.
21. BURNSTOCK, G. (1995). Noradrenaline and ATP: cotransmitters and neuromodulators. J. Physiol. Pharmacol., 46, 365-384.
22. BURNSTOCK, G. (1996a). P2 Purinoceptors: historical perspective and classification. Ciba Foundation Symposium. 198. In: P2 Purinoceptors: Localization, Function and Transduction Mechanisms, pp. 1-29. John Wiley and Sons, Chichester.
23. BURNSTOCK, G. (Ed.) (1996b). Purinergic neurotransmission. Sem. Neurosci., 8, 171-257.
24. BURNSTOCK, G. (1996c). A unifying purinergic hypothesis for the initiation of pain. Lancet, 347, 1604-1605.
25. 2-purinoceptor?. Gen. Pharmacol., 16, 433-440.
26. BURNSTOCK, G. & KENNEDY, C. (1986). A dual function for adenosine 5′-triphosphare in the regulation of vascular tone. Excitatory cotransmitter with noradrenaline from perivascular nerves and locally released inhibitory intravascular agent. Circ. Res., 58, 319-330.
27. 2 purinoceptors. Drug Dev. Res., 38, 67-71.
28. BURNSTOCK, G. & RALEVIC, V. (1996). Cotransmission. In: The Pharmacology of Vascular Smooth Muscle, pp. 210-232. Eds. C.J. Garland & J.A. Angus, Oxford University Press, Oxford.
29. BURNSTOCK, G. & WOOD, J.N. (1996). Purinergic receptors: their role in nociception and primary afferent neurotransmission. Curr. Opin. Neurobid., 6, 526-532.
30. BURNSTOCK, G., CAMPBELL G., BENNETT, M. & HOLMAN, M.E. (1963). Inhibition of the smooth muscle of the taenia coli. Nature, 200, 581-582.
31. BURNSTOCK, G., CAMPBELL, G., SATCHELL, D. & SMYTHE, A. (1970). Evidence that adenosine triphosphate or a related nucleotide is the transmitter substance released by non-adrenergic inhibitory nerves in the gut. Br. J. Pharmacol., 40, 668-688.
32. 2Y subtypes. Drug Dev. Res., 31, 206-219.
33. CHEN, C., AKOPIAN, A.N., SIVILOTTI, L., COLQUHOUN, D., BURNSTOCK, G. & WOOD, J.N. (1995). A subset of sensory neurons express a novel P2X receptor. Nature, 377, 428-431.
34. 6 receptors and the distribution and properties of an extended family of ATP-gated ion channels. J. Neurosci., 16, 2495-2507.
35. 6 receptor. Biochem. Biophys. Res. Commun. 222, 303-308.
36. COMMUNI, D., PIROTTON, S., PERMENTIER, M. & BOEYNAEMS, J.-M. (1996b). Cloning and functional expression of a human uridine nucleotide receptor. J. Biol. Chem., 270, 30849-30852.
37. CORR, L. & BURNSTOCK, G. (1991). Vasodilator response of coronary smooth muscle to the sympathetic cotransmitters noradrenaline and adenosine 5′-triphosphate. Br. J. Pharmacol., 104, 337-342.
38. DE MEY, J., BURNSTOCK, G. & VANHOUTTE, P.M. (1979). Modulation of the evoked release of noradrenaline in canine saphenous vein via presynaptic receptors for adenosine but not ATP. Eur. J. Pharmacol., 55, 401-405.
39. DE MEY, J.G. & VANHOUTTE, P.M. (1981). Role of the intima in cholinergic and purinergic relaxation of isolated canine femoral arteries. J. Physiol. (Lond.), 316, 347-355.
40. DRURY, A.N. & SZENT-GYÖRGY, A. (1929). The physiological activity of adenine compounds with special reference to their action upon the mammalian heart. J. Physiol. (Lond)., 68, 213-237.
41. DUBYAK, G.R. (1991). Signal transduction by P2-purinergic receptors for extracellular ATP. Am. J. Respir. Cell Biol., 4, 295-300.
42. ECCLES, J.C. (1964). The Physiology of Synapses. Springer Verlag, Berlin.
43. EVANS, R.J. & SUPRENANT, A. (1992). Vasoconstriction of guinea-pig submucosal arterioles following sympathetic nerve stimulation is mediated by the release of ATP. Br. J. Pharmacol., 106, 242-249.
44. FREDHOLM, B.B., ABBRACCHIO, M.P., BURNSTOCK, G., DALY, J.W., HARDEN, T.K., JACOBSON, K.A LEFF, P. & WILLIAMS, M. (1994). VI. Nomenclature and classification of purinoceptors. Pharmacol. Rev., 46, 143-156.
45. FURCHGOTT, R.F. & ZAWADZKI, J.V. (1980). The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature, 288, 373-176.
46. GAARDER, A., JONSEN, J., LALAND, S., HELLEM, A. & OWXEN, P.A. (1961). Adenosine diphosphate in red cells as a factor in the adhesiveness of human blood platelets. Nature, 192, 531-532.
47. 2 purinoceptors. Drug Dev. Res., 31, 274.
48. GORDON, J.L. (1986). Extracellular ATP: effects, sources and fate. Biochem. J., 233, 309-319.
49. 2-purinergic receptors: subtype-associated signalling responses and structure. Ann. Rev. Pharmacol. Toxicol., 35, 541-549.
50. HOLTON, P. (1959). The liberation of adenosine triphosphate on antidromic stimulation of sensory nerves. J. Physiol. (Lond.), 145, 494-504.
51. HOURANI, S.M.O. & CUSACK, N.J. (1991). Pharmacological receptors on blood platelets. Pharmacol. Rev., 43, 243-298.
52. 2T purinoceptor antagonists: definition of the role of ADP in arterial thrombosis. TIPS, 16, 179-181.
53. INOUE, T. & KANKAN, M.S. (1988). Nonadrenergic and noncholinergic excitatory neurotransmission in rat intrapulmonary artery. Am. J. Physiol., 254, H1142-H1148.
54. 2 rather than of the A subtype. Eur. J. Pharmacol., 100, 363-368.
55. 2X purinoceptors be classified pharmacologically? TIPS, 16, 168-174.
56. 3 receptor subunits can account for ATP-gated currents in sensory neurones. Nature, 377, 432-435.
57. LUSTIG, K.D., SHIAU, A.K., BRAKE, A.J. & JULIUS, D. (1993). Expression cloning of an ATP receptor from mouse neuroblastoma cells. Proc. Natl. Acad. Sci. USA., 90, 5113-5117.
58. MARTIN, P.L. & POTTS, A.A. (1994). The endothelium of the rat renal artery plays an obligatory role in A2 adenosine receptor-mediated relaxation induced by 5′-N-ethylcarboxamidoadenosine and N6-cyclopentyladenosine. J. Pharmacol. Exp. Ther., 270, 893-899.
59. MARTINSON, J. & MUREN, A. (1963). Excitatory and inhibitory effects of vagus stimulation on gastric motility in the cat. Acta Physiol. Scand., 57, 309-316.
60. MILNER, P., BODIN, P., LOESCH, A. & BURNSTOCK, G. (1995). Interactions between sensory perivascular nerves and the endothelium in brain microvessels. Int. J. Microcirc., 15, 1-9.
61. MILNER, P., LOESCH, A. & BURNSTOCK, G. (1996). Neonatal sensory denervation affects the expression of endothelial peptides in the adult rat pulmonary artery: more cells contain substance P and less contain endothelin. Endothelium, 4, 71-76.
62. MIYAHARA, H. & SUZUKI, H. (1987). Pre- and post-junctional effects of adenosine triphosphate on noradrenergic transmission in the rabbit ear artery. J. Physiol., 389, 423-440.
63. 1-purinoceptors by ATP depends partly on its conversion to AMP and adenosine and partly on direct action. Eur. J. Pharmacol., 97, 47-54.
64. NEELY, C.F., MATOT, L. BATRA, V.K., BO, X. & BURNSTOCK, G. (1996). P2x purinoceptors in the feline pulmonary vascular bed: distribution and selective in vivo pharmacological probes. Am. J. Physiol., 270, L889-L897.
65. NGUYEN, T., ERB, L., WEISMAN, G.A., MARCHESE, A., HENG, H.H.Q., GARRAD, R.C., GEORGE, S.R. et al. (1996). Cloning, expression and chromosomal localization of the uridine nucleotide receptor gene. J. Biol. Chem., 270, 30845-30848.
66. NORTH, R.A. (1996). P2X plethora. Sem Neurosci., 8, 187-194.
67. O'CONNOR, S.E., DAINTY, I.A. & LEFF, P. (1991). Further subclassification of ATP receptors based on agonist studies. Trends Pharmacol. Sci., 12, 137-141.
68. OLSSON, R.A. & PEARSON, J.D. (1990). Cardiovascular purinoceptors. Physiol. Rev., 70, 761-845.
69. PATON, D.M. (1981). Presynaptic neuromodulation mediated by purinergic receptors. In: Purinergic Receptors, pp. 199-262. Ed. G. Burnstock. Chapman & Hall, London.
70. xA) as new neurotransmitters. Drug. Dev. Res., 28, 259-262.
71. RALIVIC, V. & BURNSTOCK, G. (1990). Postjunctioual synergism of noradrenaline and adenosine 5′-triphosphate in the mesenteric arterial bed of the rat. Eur. J. Pharmacol., 175, 291-299.
72. 2-purinoceptors in the cardiovascular system. Circulation, 84, 1-14.
73. RALEVIC, V. & BURNSTOCK, G. (1991b). Effects of purines and pyrimidines in the rat mesenteric arterial bed. Circ. Res., 69, 1583-1590.
74. RALEVIC, V. & BURNSTOCK, G. (1996a). Mesenteric arterial function in the rat in pregnancy: role of sympathetic and sensory-motor perivascular nerves, endothelium, smooth muscle, nitric oxide and prostaglandins. Br. J. Pharmacol., 117, 1463-1470.
75. 2u-purinoceptors in the rat isolated mesenteric arterial bed. Br. J. Pharmacol., 118, 428-434.
76. RALEVIC, V., BELAL, A. & BURNSTOCK, G. (1993). Impaired sensory-motor nerve function in the isolated mesenteric arterial bed of streptozotocin-diabetic and ganglioside-treated streptozotocin-diabetic rats. Br. J. Pharmacol., 110, 1105-1111.
77. RALEVIC, V., HOYLE, C.H.V., GOSS-SAMPSON, M.A., MILLA, P.J. & BURNSTOCK, G. (1996). Effect of chronic vitamin E deficiency on sympathetic and sensorimotor function in rat mesenteric arteries. J. Physiol., 490.1, 181-189.
78. RAMME, D., REGENOLD, J.T., STARKE, K., BUSSE, R. & ILLES, P. (1987). Identification of the neuroeffector transmitter in jejunal branches of the rabbit mesenteric artery. Naunyn Schmiedeberg's Arch. Pharmacol., 336, 267-273.
79. 2-purinoceptor mediating vasoconstriction by UTP, ATP and related nucleotides in the isolated pulmonary vascular bed of the rat. Br. J. Pharmacol., 118, 1415-1420.
80. 2-purinoceptors to the control of vascular tone in the rat isolated mesenteric arterial bed. Br. J. Pharmacol., 115, 648-652.
81. SALAG, B., BODIN, P., SHACOORI, V., CATHELINE, M., RAULT, B. & BURNSTOCK, G. (1995). Uptake and flow-induced release of uridine nucleotides from isolated vascular endothelial cells. Endothelium, 2, 279-285.
82. SHIMADA, S.G. & STITT, J.T. (1984). An analysis of the purinergic component of active muscle vasodilatation obtained by electrical stimulation of the hypothalamus in rabbits. Br. J. Pharmacol., 83, 577-589.
83. STEINHORN, R.H., MORIN, F.C., VAN WYLEN, D.G.L., GUGINO, S.E., GIESE, E.C. & RUSSELL, J.A. (1994). Endothelium-dependent relaxations to adenosine in juvenile rabbit pulmonary arteries and veins. Am. J. Physiol., 266, H2001-H2006.
84. 7). Science, 272, 735-738.
85. VALERA, S., HUSSY, N., EVANS, R.J., ADAMI, N., NORTH, R.A., SURPRENANT, A. & BUELL, G. (1994). A new class of ligand-gated ion channel defined by P2x receptor for extracellular ATP. Nature, 371, 516-519.
86. 2Y-purinoceptor using rhodopsin as template. Drug Design Discovery, 13, 133-154.
87. 2-purinoceptor-mediated relaxation in the guinea-pig coronary vasculature: a role for nitric oxide. Br. J. Pharmacol., 109, 424-429.
88. VIDAL, M., HICKS, P.E. & LANGER, S.Z. (1986). Differential effects of alpha,beta-methylene ATP on responses to nerve stimulation in SHR and WKY tail arteries. Naunyn-Schmiedeberg's Arch Pharmacol., 332, 384-390.
89. 2-purinoceptor-mediated inhibition of noradrenaline release in rat atria. Br. J. Pharmacol., 115, 247-254.
90. WEBB, T.E., SIMON, J., KRISHEK, B.J., BATESON, A.N. SMART, T.G., KING, B., BURNSTOCK, G. & BARNARD, E.A. (1993). Cloning and functional expression of a brain G-coupled ATP receptor. FEBS Lett., 324, 219-225.